无 KM 图
入排:排除
图源:待检查
Expression of Concern: Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial.
The Editors Of The Lancet
Lancet 407(10548) 2588
AI 判定该论文不进入自动 KM 提取:Publication is an 'Expression of Concern' about a trial, not the primary trial results report.
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板